Philadelphia Trust CO Abbott Laboratories Transaction History

Philadelphia Trust CO

$1.29 Billion
Q2 2024

A detailed history of Philadelphia Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Philadelphia Trust CO holds 287,378 shares of ABT stock, worth $32.3 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

287,378

Previous 284,520 1.0%

Holding current value

$32.3 Million

Previous $32.3 Million 7.66%

% of portfolio

2.32%

Previous 2.6%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $287,886 - $321,353	2,858 Added 1.0%	287,378 $29.9 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $565,889 - $625,000	5,167 Added 1.85%	284,520 $32.3 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $488,018 - $597,374	-5,411 Reduced 1.9%	279,353 $30.7 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $870,660 - $1.04 Million	-9,114 Reduced 3.1%	284,764 $27.6 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $410,880 - $457,806	-4,077 Reduced 1.37%	293,878 $32 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $785,147 - $924,165	-8,106 Reduced 2.65%	297,955 $30.2 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $1.86 Million - $2.18 Million	-19,541 Reduced 6.0%	306,061 $33.6 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $336,434 - $389,528	-3,477 Reduced 1.06%	325,602 $31.5 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $1.21 Million - $1.46 Million	-11,840 Reduced 3.47%	329,079 $35.8 Million
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $999,157 - $1.22 Million	-8,763 Reduced 2.51%	340,919 $40.4 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $3.24 Million - $3.96 Million	28,012 Added 8.71%	349,682 $49.2 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $7.22 Million - $7.99 Million	-61,906 Reduced 16.14%	321,670 $38 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $1.93 Million - $2.27 Million	-18,261 Reduced 4.54%	383,576 $44.5 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $939,615 - $1.11 Million	-8,633 Reduced 2.1%	401,837 $48.2 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $1.39 Million - $1.51 Million	-13,206 Reduced 3.12%	410,470 $44.9 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $543,333 - $659,838	5,929 Added 1.42%	423,676 $46.1 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $1.19 Million - $1.52 Million	15,550 Added 3.87%	417,747 $38.2 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $958,633 - $1.4 Million	-15,260 Reduced 3.66%	402,197 $31.7 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $823,962 - $917,263	-10,495 Reduced 2.45%	417,457 $36.3 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $3.56 Million - $3.86 Million	-43,495 Reduced 9.23%	427,952 $35.8 Million
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $1.28 Million - $1.49 Million	-17,500 Reduced 3.58%	471,447 $39.6 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $3.62 Million - $4.38 Million	-54,718 Reduced 10.06%	488,947 $39.1 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $5.52 Million - $6.25 Million	-84,127 Reduced 13.4%	543,665 $39.3 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.01 Million - $1.22 Million	16,623 Added 2.72%	627,792 $46.1 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $2.9 Million - $3.2 Million	-50,321 Reduced 7.61%	611,169 $37.3 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $2.93 Million - $3.31 Million	-52,067 Reduced 7.3%	661,490 $39.6 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $141,232 - $151,203	2,631 Added 0.37%	713,557 $40.7 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $34.2 Million - $38.1 Million	710,926	710,926 $37.9 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account

Philadelphia Trust CO Abbott Laboratories Transaction History